We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RENX market cap is 41.4M. The company's latest EPS is USD -0.1373 and P/E is -0.91.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 339k | 1.49M | 2.97M | 3.4M | 2.29M |
| Operating Income | -10.8M | -34.72M | -57.24M | -32.19M | -31.89M |
| Net Income | -9.25M | -31.01M | -56.73M | -46.22M | -45.47M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.3M | 102.58M | 63.26M | 42.12M | 7.1M |
| Total Liabilities | 5.34M | 7.48M | 20.09M | 23.66M | 16.08M |
| Total Equity | 35.96M | 95.1M | 43.17M | 18.45M | -8.98M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.06M | -24.63M | -45.75M | -32.67M | -29.83M |
| Investing | -849k | -741k | -694k | N/A | 117k |
| Financing | 16.85M | 77.24M | 25.52M | 15.12M | 10.09M |
| Market Cap | 41.4M |
| Price to Earnings Ratio | -0.91 |
| Price to Sales Ratio | 18.12 |
| Price to Cash Ratio | 8.87 |
| Price to Book Ratio | -4.61 |
| Dividend Yield | - |
| Shares Outstanding | 331.21M |
| Average Volume (1 week) | 564.8k |
| Average Volume (1 Month) | 468.37k |
| 52 Week Change | -24.24% |
| 52 Week High | 71.50 |
| 52 Week Low | 6.75 |
| Spread (Intraday) | 1 (7.69%) |
| Company Name | Renalytix Plc |
| Address |
2 leman street london E1W 9US |
| Website | https://renalytix.com |
| Industry | services, nec (8999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
